Catalyst Wire Dossier Catalyst Wire Dossier

Edarbi

azilsartan medoxomil · Takeda Pharma A/S
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Edarbi, covering 2011-02-25 to 2025-01-29. Get the full timeline:

Most recent: EMA Authorised: Edarbi (azilsartan medoxomil) — Takeda Pharma A/S

See pricing